A new report from the United Kingdom revealed that the medical industry’s justification for giving puberty blockers and cross-sex hormones to minors is based on “remarkably weak” evidence stemming from “poor quality of the published studies,” and “misinformation." At the same time, the industry exhibits “expectations of care” that are “far from usual clinical practice,” Dr. Susan Berry writes. READ
No comments:
Post a Comment